Intestinal Microbiota in Stem Cell Transplant Transplant Admission
ConditionStem Cell Transplant Complications
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHenry Ford Health System
About this trial
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-80 years
patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure
Disqualifiers
None
Trial population
stem cell transplant patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
intestinal microbiota
Diagnostic testStoll samples will be tested for different bacteria
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Changes in microbiome
Time frame
Up to 6 months post stem cell transplantSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov